Transcriptional repression needs to be rapidly reversible during embryonic 2 development. This extends to the Hedgehog pathway, which primarily serves to counter 3 GLI repression by processing GLI proteins into transcriptional activators. In investigating 4 the mechanisms underlying GLI repression, we find that a subset of these regions, 5
INTRODUCTION 15
Transcriptional repressors employ distinct mechanisms for regulating gene expression. 16
Long-term repression is accompanied by topological and biochemical changes to DNA 17 that can lock down transcription within a cell lineage. In contrast, transient repression is 18 rapidly reversible, providing a mechanism for controlling gene activation during the 19 dynamic process of embryogenesis. This control is especially important for spatially 20 restricting gene expression until signal transduction mechanisms alleviate repressor 21
activity. 22
For example, the induction of HH signaling within the posterior half of the developing 24 limb bud rapidly inhibits the formation of truncated GLI repressor proteins, instead 25 promoting the production of full-length GLI transcriptional activators (Harfe et al. 2004) . 26
Consequently, GLI activators are found within the posterior limb bud in cells receiving 27 the HH ligand while GLI repressors in the anterior limb bud spatially restrict the domains 28 of HH target gene expression (Wang et al. 2000 ; Ahn and Joyner 2004) . As a repressor-29 driven system, most transcriptional targets do not actually require GLI activator for 30 transcription, but can be activated by loss of GLI repressor alone. This property of de-31 repression rather than activation is exemplified by Shh -/limb buds (constitutive GLI 32 repression, no GLI activation), which have a nearly complete absence of digits and a 33 severe reduction in limb size. The phenotype is markedly improved in double mutants 34 that lack most or all GLI activity (Litingtung et repression is sufficient to activate most GLI target genes in the limb bud, suggesting 37 that the primary role of the HH pathway is to alleviate GLI repression (Lewandowski et 38 al. 2015) . The labile nature of GLI repression represents a key mechanism for the 39 dynamic transcriptional regulation of HH targets as HH induction rapidly inactivates GLI 40 repression, resulting in transcription of targets within 4-9 hours of stimulation (Harfe et 41 al. 2004; Panman et al. 2006) . 42
43
The mechanism underlying GLI repression is unknown but could in principle function 44 either by excluding GLI activator binding or by recruiting co-repressors (Wang et al. 45 2010) . Although the former category provides an attractive model for how GLI proteins 46 might interpret gradients of HH ligand (Falkenstein and Vokes 2014) , it fails to account 47 for the large number of GLI target genes that are fully activated upon de-repression in 48 the absence of HH signaling. 49 50 Several GLI co-repressors have been identified in various contexts, including Atrophin 51 (Zhang et al. 2013 ), Ski (Dai et al. 2002 ) and tissue-specific transcription factors 52 (Oosterveen et al. 2012 ). Members of the BAF chromatin remodeling complex have also 53 been shown to regulate GLI repressor activity; however, as these mutations also affect 54 GLI-activation, it is unclear if they specifically mediate repressive activity or if they are 55 essential for all GLI transcriptional response (Jagani et al. 2010; Zhan et al. 2011; Jeon 56 and Seong 2016; Shi et al. 2016 ). Additionally, GLI activators have been shown to 57 recruit the histone-demethylase JMJD3 to remove H3K27Me3, a mark that is placed by 58 the Polycomb Repressor Complex 2 (PRC2), leading to subsequent activation (Shi et al. 59 2014; Weiner et al. 2016 ). Other studies have also suggested interactions between 60
Polycomb repression and HH signaling in the limb bud (Wyngaarden et al. 2011 ; 61 Deimling et al. 2018) . Because mutations in these candidates are pleiotropic, it has 62 been challenging to determine if they directly mediate GLI repression, a task 63 compounded by the dual roles of GLI proteins as transcriptional activators and 64 repressors. 65
66
We have used a genomic approach to determine if the chromatin modifications at GLI 67 binding regions (GBRs) are altered in response to GLI repression. We hypothesized 68 that GLI repressors regulate gene expression by inactivating enhancer activity. 69
Consistent with this, we find that GLI repression regulates enhancer activity through the 70 de-acetylation of Histone H3K27. This repression occurs independently of Polycomb 71 activity. Enhancers regulated in this fashion mark known GLI limb enhancers, are highly 72 enriched around HH-responsive genes, and primarily drive tissue-specific enhancer 73 activity within HH-specific domains. Collectively, the results suggest that GLI repressors 74 inhibit gene expression by altering enhancer activity, providing an explanation for the 75 labile nature of GLI repression. 76
77

RESULTS
78
A subset of GLI binding regions is epigenetically regulated by HH signaling 79
Since most HH targets can be activated by loss of GLI repression, we hypothesized that 80 enhancers may be activated by HH signaling when GLI repression is relieved. 81
To test this, we first identified active GLI enhancers in the developing limb at embryonic 82 day 10.5 (E10.5), when high levels of HH target gene expression are observed. We 83 used an endogenously FLAG tagged Gli3 allele to identify GLI3 binding regions and 84 then identified regions enriched for H3K27ac, a marker associated with active 85 enhancers, by chromatin immunoprecipitation (ChIP-seq) (Heintzman et al. 2007 ; Next, we assessed changes in H3K27ac enriched GBRs in wild-type (WT) and Sonic 92 hedgehog (Shh) null forelimbs. Since Shh -/forelimbs have constitutive GLI repression, 93
we hypothesized that in the absence of HH signaling, GLI repressor may prevent 94 activation of its enhancers. We performed ChIP-seq for H3K27ac in E10.5 forelimbs, 95 prior to overt phenotypes in Shh nulls (Chiang et al. 2001) . Although most H3K27ac 96 enriched regions were present in both WT and Shh -/embryos, a subset of 2,113 WT 97
H3K27ac enriched regions had acetylation that was significantly reduced or completely 98 lost in the absence of HH signaling (Figure 1-Source Data 2). We then asked whether 99 those regions with reduced acetylation in the absence of HH signaling include GLI-100 bound enhancers. Most GBRs with H3K27ac enrichment in WT limbs retain H3K27ac in 101
Shh -/limb buds, which we term Stable GBRs (Fig. 1C,D ). This suggests that they 102 function as active enhancers whose activity is not predominantly regulated by HH 103 signaling. Interestingly, in a smaller subset of GBRs, H3K27ac enrichment was reduced 104 or lost in the absence of HH signaling, suggesting that GLI repressor may regulate the 105 activity of this group of enhancers. Within this GBR class with HH-responsive 106 acetylation, we identified populations of GBRs that had either significant reductions 107 (termed HH-sensitive) or a complete absence of H3K27ac enrichment (termed HH-108 dependent) in Shh -/limb buds (Fig. 1C ,D). The latter two categories are henceforth 109 collectively referred to as HH-responsive GBRs. 110 111
Hedgehog-responsive GBRs are enriched near Hedgehog target genes 112
To determine if HH-responsive GBRs are associated with HH target genes, we 113 examined biologically validated GLI enhancers in the Ptch1 and Gremlin loci that 114 mediate limb-specific transcription of these HH targets and found that they are among 115 the HH-responsive class of GBRs ( Fig. 1E) possibility, we found that HH-responsive GBRs are highly enriched around genes that 119 have reduced expression in Shh -/limb buds (Lewandowski et al. 2015) . In contrast, 120
Stable GBRs have minimal enrichment, however are still significantly enriched around 121 both HH target and non-target genes (p=0, permutation test; Fig. 1G ). examined their GLI binding motifs. A higher percentage of HH-dependent and HH-139 sensitive GBRs contain GLI motifs compared to Stable GBRs. HH-dependent and HH-140 sensitive GBRs also contain a higher density and higher quality of GLI motifs compared 141
to Stable GBRs (Fig. 1I ). Interestingly, we did not uncover high levels of enrichment of 142 other motifs using de novo motif analysis ( Figure 1 of GLI repression would lead to recruitment of PRC2 and thus methylation at these 153 enhancers. Contrary to this prediction, we identified a minimal number of HH-responsive 154
GBRs enriched for H3K27me3 in E10.5 Shh -/limb buds (31/349 GBRs; Fig GBRs are accessible in WT limb buds than HH-responsive GBRs, suggesting a more 201 restricted accessibility of HH-responsive GBRs even in WT conditions ( Fig. 3B-C) . 202
Contrary to expectations for a poised enhancer, both HH-sensitive and HH-dependent 203
GBRs have significantly reduced accessibility compared to Stable GBRs in the absence 204 of HH signaling, with the majority of HH-responsive GBRs being more compact in Shh -/-205 compared to wild-type limbs ( Fig. 3D-F ). Overall, we conclude that HH-responsive 206
GBRs are less accessible than Stable GBRs, with access being further restricted in 207 Shh -/limb buds, which have constitutive GLI repression. 208 209
De-repression is the dominant mechanism regulating GLI enhancer activation 210
The presence of multiple GLI proteins and their bifunctional roles as both transcriptional 211 activators and repressors has made it challenging to determine how HH genes are 212 primarily regulated. To test this on enhancers, we performed H3K27ac ChIP in 213 Shh -/-;Gli3 -/limb buds (devoid of GLI activators and most GLI repressors). We 214 hypothesized that loss of H3K27ac at most HH-responsive enhancers is due to 215 constitutive GLI repression preventing acetylation of GLI enhancers. Thus, in 216 In a parallel series of experiments, we noted that HH-responsive GBRs have higher 239 levels of H3K27ac enrichment in posterior limb halves compared to anterior limb halves 240 ( Fig. 4G ). This contrasts with Gli3 -/limb buds, where H3K27ac levels in anterior halves 241 are comparable to those in posterior halves (Fig. 4H ), a finding that is also consistent 242 with a GLI repressor driven model. Together these results strongly support a GLI 243
repressor centric mode of regulation where GLI de-repression is responsible for 244 activation of most GLI limb enhancers. We conclude that GLI activator does not mediate 245 acetylation levels at most HH-responsive GBRs. 246
247
HDAC1 is responsible for loss of H3K27ac at HH-responsive enhancers 248
The above results support a model in which loss of an HDAC-GLI repressor complex 249 leads to acetylation. To test this, we cultured limb buds in the presence of the HDAC1/2 250 anterior limb buds ( Fig. 4I ). We conclude that GLI repressors regulate H3K27ac levels 257 at HH-responsive GBRs at least in part through HDAC1/2. 258 259
HH-responsive GBRs have increased tissue-specificity compared to Stable GBRs 260
Having identified distinct classes of GBRs that respond differently to HH signaling, we 261 next addressed the biological significance of this enhancer behavior. To this end, we 262 used the VISTA enhancer database to identify a total of 305 Stable and 23 HH-263
responsive GBRs that had been tested for enhancer activity (Visel et al. 2007 ). While 264 nearly half of each class have enhancer activity in the limb, HH-responsive GBRs tend 265 to have activity specific to the HH-responsive posterior limb bud while Stable GBRs tend 266 to have activity throughout the limb or regions that are not responsive to HH (Fig. 5A,B ) 267 which are associated with more broadly expressed genes and are not enriched near HH 324 target genes (Fig. 1G,H) . They are also more highly conserved than HH-responsive 325
GBRs (Figure 1-Figure Supplement 1D) . In contrast to HH-responsive enhancers, they 326 appear to be active in other cell types and tissues besides the limb (Fig. 6B) . One 327 possibility is that many Stable GBRs do not have a major role in mediating Hedgehog 328 signaling; GLI repressors at these regions are relatively inert. A second possibility is that 329 GLI repression at Stable GBRs mediates subtle changes to acetylation that confer small 330 reductions in transcription that are beyond the limits of our detection. Finally, it is 331 possible Stable enhancers are globally active, but engage in long-range collaborations 332 with tissue specific HH-responsive enhancers to activate transcription (Fig. 6C) . 333
334
Previous modeling has suggested that GLI repressors within an enhancer work 335 cooperatively through multiple GLI sites (Parker et al. 2011 ), providing another 336 mechanism for tuning enhancer response. HH responsive GBRs contain more GLI 337 motifs than Stable GBRs, which may make them more responsive to GLI repression, 338
although in contrast to those models, they have high quality GLI motifs. As many GLI 339 target genes, including Ptch1 and Grem1, are regulated by multiple GLI enhancers 340 The majority of HH-responsive GBRs do not have H3K27me3 enrichment even when 348 there is maximal GLI repression ( Fig. 2A-D) . This indicates that the Polycomb repressor 349 complex is not involved in mediating most GLI repression, a conclusion that seemingly increased H3K27ac enrichment in Shh -/-;Gli3 -/limbs at all of these GBRs except for 367 ones near the HH pathway genes Gli1, Ptch1 and Ptch2 (Fig. 4B) . Thus, for rare GBRs 368 requiring GLI activation, their mode of action is consistent with previously proposed 369 models in which GLI activators recruit a complex to remove H3K27Me3, resulting in the 370 activation of these enhancers and subsequently their cognate target genes (Shi et al. 371 2014) . After ChIP was performed as described above, libraries were generated using the 498 NEBNext Ultra II library preparation kit with 15 cycles of PCR amplification (NEB 499 E7645). The libraries for the 'MicroChIP' samples were generated using the MicroPlex 500 library prep kit (Diagenode C05010012) and sequenced to a depth of >40 million reads 501 per sample for both ChIP and 'MicroChIP' experiments, using two biological replicates. 502
Peaks were called using CisGenome version 2.1.0 ). To identify 503 differentially enriched peaks in the WT and Shh -/limb buds (or control and 504 purmorphamine-treated NIH3T3 cells), the peaks were merged to determine how many 505 WT, WT input, Shh -/and Shh -/input reads overlapped with the peak region. The read 506 numbers were adjusted by library size and log2 transformed after adding a pseudo-507 count of 1. The differential analysis between WT and WT input used limma (Ritchie et 508 al. 2015) . The FDR of the differential test was obtained and peaks with FDR < 0.05 are 509 determined as having differential signal between WT and WT input. The same 510 differential analysis procedure was repeated to compare between Shh -/and Shh -/-511 input, and between WT and Shh -/-. To determine GLI motif quality, de novo motif 512 discovery was performed on the 1000 GBRs with the highest quality using the 513 flexmodule_motif function in CisGenome to identify the GLI motif. The GLI motif was 514 mapped to the mouse genome using the motifmap_matrixscan_genome function in 515
CisGenome software with default parameters. 516
517
ATAC-Seq 518
Individual pairs of posterior forelimb fractions were dissected from 35 somite wildtype 519 (n=2) or Shh -/embryos (n=2). ATAC used components from the Nextera DNA Library 520
Preparation Kit (Illumina) as described previously (Buenrostro et al. 2015) with the 521 following variations. 5,000 cells from each sample were added into each reaction and 522 cells were lysed on ice for 8 min. prior to centrifugation. Libraries were generated using 523 18 cycles of PCR amplification with NEB high fidelity 2x master mix (New England 524 Biolabs), cleaned up with AMPure XP beads (Beckman Coulter) and sequenced on an 525
Illumina NextSeq 500 using PEx75 to a depth of 30 million reads. Peaks were called 526 using MACS2 with a fixed window size of 200bp and a q-value cutoff of 0.05. Differential 527 analysis of wildtype versus Shh -/peak signals was performed essentially as described 528
for ChIP above using limma (Ritchie et al. 2015) . H3K27ac peaks that are not bound by GLI3 were counted as well as the number of 817 random peaks. Only windows that overlapped with at least one HH-responsive 818
H3K27ac peak or random peak were considered. The two counts are significantly Table  861 showing the top 20 motifs uncovered from de novo motif analysis on HH-responsive 862
GBRs. The enrichment is relative to matched genomic controls. Note that 'HH_resp_2' 863 is the only motif with an enrichment value of greater than 2 and corresponds with a 864 known GLI binding motif. 865 Coordinates for all ATAC peaks in the WT group that overlap with GBRs are listed. 889 "Shh_ATAC_peak" identifies the corresponding id# for that peak in the Shh -/data, and 890 if a peak is not present in the Shh -/samples, it is marked as NA. A column for each 891 GBR type identifies which GBR type a given ATAC peak overlaps with. The number 892
indicates the peak ID. If a peak region does not overlap with the type of peak in that list, 893 it will be marked as NA. The normalized log2 transformed signals are showed for each 894 sample in addition to the "average" signal across all samples. The "t" statistic calculates 895 the difference in signals between WT and Shh -/by taking into consideration fold-896 change and variance among samples. A positive t statistic values indicate a peak is 897 more accessible in WT than Shh -/and a negative t statistic indicates higher 898 accessibility in Shh -/-. The "p.value" is obtained from a moderated t-test using limma. 899
The "p.value.adj" is the adjusted p-value (FDR) using the Benjamini-Hochberg Shh -/and Shh -/-;Gli3 -/-E10.5 (33-34S) forelimbs. Separate tabs for each genotype 905 include peak coordinates and log2 fold change over input. Additional tabs include a 906 peak summary and differential analysis of WT vs. Shh -/-;Gli3 -/-. Differential analysis tab 907 lists peak coordinates, peak type, fold change normalized to input for WT and Shh -/-908 ;Gli3 -/samples and fold change of WT over Shh -/-;Gli3 -/-. 909 peaks. H3K27ac called peaks with a FDR <0.05 from two replicates of purmorphamine 917 ("pm") treated or DMSO control NIH3T3 cells. For each peak, the assigned Peak ID, 918 coordinates, peak type, fold change normalized to input for purmorphamine treated and 919 control samples, and fold change of purmorphamine treated over control are listed. 920
Additional tabs include sorted files for each peak type. 921
